New Models for Translational Research Collaboration

1:00 PM - 2:15 PM, Monday, June 3,2019 ・ 112AB, Level 100
The expansion of new drug modalities and growth of precision medicine create new challenges and opportunities for translational research in efforts to turn biological discoveries into beneficial therapies for patients. Leaders across the biotechnology ecosystem are pioneering novel approaches to collaboration in order to improve and accelerate the drug development process. This panel will explore a variety of these collaboration models and share their lessons learned so far.
Speakers
photo
CEO
Muscular Dystrophy Association
photo
Director, National Center for Advancing Translational Sciences (NCATS)
National Institutes of Health
photo
Chief Scientific Officer and President, Worldwide Research, Development and Medical
Pfizer, Inc.
photo
President & CEO, CMO
Synlogic
photo
Executive Vice Dean and Chief Scientific Officer William Wikoff Smith Professor of Cardiovascular Research Department of Medicine
Perelman School of Medicine University of Pennsylvania